RELX PLC / Springer Nature: Claude Science - what impact on LeapSpace?

Research evidence excerpt

RELX PLC / Springer Nature: Claude Science - what impact on LeapSpace?

Equity Research

1 July 2026

RELX PLC / Springer Nature

Claude Science - what impact on

LeapSpace? First Look

Anthropic has launched an AI workbench for scientists: REL.L/REL LN OVERWEIGHT

Claude Science. Given their offering in Life Sciences this is not European Media NEUTRAL

surprising, but it will raise questions about competition with Price Target GBp 3095

Price (30-Jun-26) GBp 2366

Elsevier's LeapSpace. That is aimed at engaging with Potential Upside/Downside +30.8%

literature and writing, but there is still potential overlap. Source: Bloomberg, Barclays Research

SPGG.DE/SPG GY OVERWEIGHT

Anthropic has launched “Claude Science,” an AI workbench for scientists aimed at accelerating European Media NEUTRAL

scientific research workflows. The workbench integrates with scientific datasets and lab Price Target EUR 24.00

processes, aiming to improve hypothesis generation, experiment design and literature Price (30-Jun-26) EUR 19.36

synthesis. It is focused on allowing scientists to plan research processes, working across many Potential Upside/Downside +24.0%

databases more easily. There is a generalist co-ordinating agent and users can develop their Source: Bloomberg, Barclays Research

own specialist ones. This builds on Claude for Life Sciences, which was released in October

2025.

European Media

Given that OpenAI launched Prism in this space (now shuttered), and given the earlier Anthropic Nick Dempsey

release in Life Sciences, this new offering from Anthropic is not too surprising. But it will make +44 (0)20 3134 5888

nick.dempsey@barclays.cominvestors think again about the LLM groups moving into vertical professional spaces with their

Barclays, UK

own tools.

Claude Science vs. RELX's LeapSpace